<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31711033</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.</ArticleTitle><Pagination><StartPage>102054</StartPage><MedlinePgn>102054</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102054</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2019.102054</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(19)30401-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Brainstem pathology is a hallmark feature of ALS, yet most imaging studies focus on cortical grey matter alterations and internal capsule white matter pathology. Brainstem imaging in ALS provides a unique opportunity to appraise descending motor tract degeneration and bulbar lower motor neuron involvement.</AbstractText><AbstractText Label="METHODS">A prospective longitudinal imaging study has been undertaken with 100 patients with ALS, 33 patients with PLS, 30 patients with FTD and 100 healthy controls. Volumetric, vertex and morphometric analyses were conducted correcting for demographic factors to characterise disease-specific patterns of brainstem pathology. Using a Bayesian segmentation algorithm, the brainstem was segmented into the medulla, pons and mesencephalon to measure regional volume reductions, shape analyses were performed to ascertain the atrophy profile of each study group and region-of-interest morphometry was used to evaluate focal density alterations.</AbstractText><AbstractText Label="RESULTS">ALS and PLS patients exhibit considerable brainstem atrophy compared to both disease- and healthy controls. Volume reductions in ALS and PLS are dominated by medulla oblongata pathology, but pontine atrophy can also be detected. In ALS, vertex analyses confirm the flattening of the medullary pyramids bilaterally in comparison to healthy controls and widespread pontine shape deformations in contrast to PLS. The ALS cohort exhibit bilateral density reductions in the mesencephalic crura in contrast to healthy controls, central pontine atrophy compared to disease controls, peri-aqueduct mesencephalic and posterior pontine changes in comparison to PLS patients. CONCLUS: ions: Computational brainstem imaging captures the degeneration of both white and grey matter components in ALS. Our longitudinal data indicate progressive brainstem atrophy over time, underlining the biomarker potential of quantitative brainstem measures in ALS. At a time when a multitude of clinical trials are underway worldwide, there is an unprecedented need for accurate biomarkers to monitor disease progression and detect response to therapy. Brainstem imaging is a promising addition to candidate biomarkers of ALS and PLS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bede</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland. Electronic address: bedep@tcd.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chipika</LastName><ForeName>Rangariroyashe H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finegan</LastName><ForeName>Eoin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li Hi Shing</LastName><ForeName>Stacey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doherty</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hengeveld</LastName><ForeName>Jennifer C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vajda</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Siobhan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, St James's Hospital, James's St, Ushers, Dublin 8 D08 NHY1, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donaghy</LastName><ForeName>Colette</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Western Health &amp; Social Care Trust, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLaughlin</LastName><ForeName>Russell L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardiman</LastName><ForeName>Orla</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MCLAUGHLIN/OCT15/957-799</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Brainstem</Keyword><Keyword MajorTopicYN="N">Longitudinal study</Keyword><Keyword MajorTopicYN="N">Medulla</Keyword><Keyword MajorTopicYN="N">Mesencephalon</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword><Keyword MajorTopicYN="N">Pons</Keyword><Keyword MajorTopicYN="N">Primary lateral sclerosis</Keyword></KeywordList><CoiStatement>Peter Bede is a member of the UK Motor Neuron Disease Association (MNDA) Research Advisory Panel, the steering committee of Neuroimaging Society in ALS (NiSALS) and the medical patron of the Irish Motor Neuron Disease Association (IMNDA). These affiliations had no impact on the design, analyses, and presentation of this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31711033</ArticleId><ArticleId IdType="pmc">PMC6849418</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2019.102054</ArticleId><ArticleId IdType="pii">S2213-1582(19)30401-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chipika R.H., Finegan E., Li Hi Shing S. Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front. Neurol. 2019;10:229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6433752</ArticleId><ArticleId IdType="pubmed">30941088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H., Brooks B.R., Silani V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol. 2014;13(11):1127&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316019</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Elamin M., Hardiman O. Presymptomatic and longitudinal neuroimaging in neurodegeneration&#x2013;from snapshots to motion picture: a systematic review. J. Neurol. Neurosurg. Psychiatry. 2015;86(10):1089&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pubmed">25632156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Doherty C.P., Elamin M. Springer International Publishing; Switzerland: 2016. Neurodegenerative Disorders: A Clinical Guide; pp. 1&#x2013;336. 2016 ed. 2016, Springer Cham Heidelberg New York Dordrecht London&#xa9;Springer International Publishing.</Citation></Reference><Reference><Citation>Omer T., Finegan E., Hutchinson S., Doherty M., Vajda A., McLaughlin R.L., Pender N., Hardiman O., Bede P. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(7-8):611&#x2013;623. Epub 2017 May 31.PMID: 28562080.</Citation><ArticleIdList><ArticleId IdType="pubmed">28562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A., Elamin M. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J. Neurol. Neurosurg. Psychiatry. 2013;84(7):766&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">23085933</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Elamin M., Hardiman O. The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration. Eur. J. Neurol. 2016;23(8):1361&#x2013;1371.</Citation><ArticleIdList><ArticleId IdType="pubmed">27207250</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini N., Douaud G., Mackay C.E. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 2010;75(18):1645&#x2013;1652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2974368</ArticleId><ArticleId IdType="pubmed">21041787</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Elamin M., Byrne S. Patterns of cerebral and cerebellar white matter degeneration in ALS. J. Neurol. Neurosurg. Psychiatry. 2015;86(4):468&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4392231</ArticleId><ArticleId IdType="pubmed">25053771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A.L., Byrne S. Spinal cord markers in ALS: diagnostic and biomarker considerations. Amyotroph. Lateral Scler. 2012;13(5):407&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">22329869</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili M.M., Querin G., Bede P. Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts-novel techniques. Front Neurol. 2019;10:350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6474186</ArticleId><ArticleId IdType="pubmed">31031688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebouteux M.V., Franques J., Guillevin R. Revisiting the spectrum of lower motor neuron diseases with snake eyes appearance on magnetic resonance imaging. Eur. J. Neurol. 2014;21(9):1233&#x2013;1241.</Citation><ArticleIdList><ArticleId IdType="pubmed">24847978</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M., Pinto-Grau M., Burke T. Identifying behavioural changes in ALS: validation of the beaumont behavioural inventory (BBI) Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18(1&#x2013;2):68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">27894191</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol. 2017;4:305&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5420811</ArticleId><ArticleId IdType="pubmed">28491898</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T., Elamin M., Bede P., Pinto-Grau M., Lonergan K., Hardiman O., Pender N. Discordant performance on the &#x2018;Reading the Mind in the Eyes&#x2019; Test, based on disease onset in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7-8):467&#x2013;472. Epub 2016 May 6.PMID: 27152765.</Citation><ArticleIdList><ArticleId IdType="pubmed">27152765</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F., Karavasilis E., Rentzos M. Clinical and radiological markers of extra-motor deficits in amyotrophic lateral sclerosis. Front. Neurol. 2018;9:1005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262087</ArticleId><ArticleId IdType="pubmed">30524366</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E., Chipika R.H., Li Hi Shing S. The clinical and radiological profile of primary lateral sclerosis: a population-based study. J. Neurol. 2019;266:2718&#x2013;2733.</Citation><ArticleIdList><ArticleId IdType="pubmed">31325016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasseroleslami B., Dukic S., Broderick M., Mohr K., Schuster C., Gavin B., McLaughlin R., Heverin M., Vajda A., Iyer P.M., Pender N., Bede P., Lalor E.C., Hardiman O. Characteristic Increases in EEG Connectivity Correlate With Changes of Structural MRI in Amyotrophic Lateral Sclerosis. Cereb Cortex. 2019;29(1):27&#x2013;41. PMID: 29136131.</Citation><ArticleIdList><ArticleId IdType="pubmed">29136131</ArticleId></ArticleIdList></Reference><Reference><Citation>Feron M., Couillandre A., Mseddi E. Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study. J. Neurol. 2018;265:2125&#x2013;2136.</Citation><ArticleIdList><ArticleId IdType="pubmed">29995291</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F., Karavasilis E., Rentzos M. Hippocampal pathology in amyotrophic lateral sclerosis: selective vulnerability of subfields and their associated projections. Neurobiol. Aging. 2019;84:178&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">31629116</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi M., de Marco G., Couillandre A. Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changes. Eur. J. Neurol. 2019 PMID: 31310452.</Citation><ArticleIdList><ArticleId IdType="pubmed">31310452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Querin G., Pradat P.F. The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Curr. Opin. Neurol. 2018;31(4):431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">29750730</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke J.L., Jackson J.H. On a case of muscular atrophy, with disease of the spinal cord and medulla oblongata. Med. Chir. Trans. 1867;50(1):489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2147915</ArticleId><ArticleId IdType="pubmed">20896302</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y., Plowman E.K., Green J.R. Clinical measures of bulbar dysfunction in ALS. Front. Neurol. 2019;10:106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389633</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Hardiman O. Lessons of ALS imaging: pitfalls and future directions&#x2014;a critical review. NeuroImage Clin. 2014;4(0):436&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3950559</ArticleId><ArticleId IdType="pubmed">24624329</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74(1):20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G., Bede P., Marchand-Pauvert V. Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review. Front. Neurol. 2018;9:844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6191472</ArticleId><ArticleId IdType="pubmed">30364135</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Nakagomi Y., Kobayashi Y. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am. J. Pathol. 1998;153(3):695&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1853004</ArticleId><ArticleId IdType="pubmed">9736019</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E., Chipika R.H., Shing S.L.H., Hardiman O., Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3-4):133&#x2013;145. Epub 2019 Jan 18.PMID: 30654671.</Citation><ArticleIdList><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F., Prvulovic D., O'Dwyer L. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog. Neurobiol. 2011;95(4):649&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3230745</ArticleId><ArticleId IdType="pubmed">21911035</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D., Moreau C., Kyheng M. A ferroptosis-based panel of prognostic biomarkers for amyotrophic lateral sclerosis. Sci. Rep. 2019;9(1):2918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393674</ArticleId><ArticleId IdType="pubmed">30814647</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Patin F., Descat A. A pharmaco-metabolomics approach in a clinical trial of ALS: identification of predictive markers of progression. PLoS One. 2018;13(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5988280</ArticleId><ArticleId IdType="pubmed">29870556</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 2000;1(5):293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H., Cheng B., Katz I.B. The natural history of primary lateral sclerosis. Neurology. 2006;66(5):647&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer Mismatch Negativity as an Indicator of Cognitive Sub-Domain Dysfunction in Amyotrophic Lateral Sclerosis. Front Neurol. 2017;8:395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5559463</ArticleId><ArticleId IdType="pubmed">28861032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001;5(2):143&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">11516708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging. 2001;20(1):45&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11293691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Omer T., Finegan E. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav. 2018;12(6):1696&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Patenaude B., Smith S.M., Kennedy D.N. A bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage. 2011;56(3):907&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3417233</ArticleId><ArticleId IdType="pubmed">21352927</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias J.E., Van Leemput K., Bhatt P. Bayesian segmentation of brainstem structures in MRI. Neuroimage. 2015;113:184&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434226</ArticleId><ArticleId IdType="pubmed">25776214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3685476</ArticleId><ArticleId IdType="pubmed">22248573</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler A.M., Ridgway G.R., Webster M.A. Permutation inference for the general linear model. Neuroimage. 2014;92:381&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010955</ArticleId><ArticleId IdType="pubmed">24530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002;15(1):1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871862</ArticleId><ArticleId IdType="pubmed">11747097</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan R.S., Segonne F., Fischl B. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster J.L., Woldorff M.G., Parsons L.M. Automated talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000;10(3):120&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871915</ArticleId><ArticleId IdType="pubmed">10912591</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Elamin M., Bede P. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11(3):232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A.L., Byrne S. Multiparametric mri study of als stratified for the C9orf72 genotype. Neurology. 2013;81(4):361&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772833</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId></ArticleIdList></Reference><Reference><Citation>Project Min, E.A.L.S.S.C. Project mine: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. EJHG. 2018;26(10):1537&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., McLaughlin R.L., Byrne S. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J. Med. Genet. 2013;50(11):776&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812897</ArticleId><ArticleId IdType="pubmed">23881933</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O., Shatunov A., Jones A.R. Development of a smartphone app for a genetics website: the amyotrophic lateral sclerosis online genetics database (ALSoD) JMIR Mhealth Uhealth. 2013;1(2):e18. PMID: 25098641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4114449</ArticleId><ArticleId IdType="pubmed">25098641</ArticleId></ArticleIdList></Reference><Reference><Citation>Klebe S., Stevanin G., Depienne C. Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting. Rev. Neurol. (Paris) 2015;171(6&#x2013;7):505&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">26008818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Elamin M., Byrne S. Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">24344910</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N.K., Aoki S., Okabe S. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology. 2008;70(7):528&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">18268244</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H., Lim C.C., Ma L. Combined MR spectroscopic imaging and diffusion tensor mri visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J. Neurol. 2004;251(10):1249&#x2013;1254.</Citation><ArticleIdList><ArticleId IdType="pubmed">15503106</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller H.P., Turner M.R., Grosskreutz J. A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2016;87(6):570&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot M., Bede P., Turner M.R. Imaging cerebral activity in amyotrophic lateral sclerosis. Front. Neurol. 2018;9:1148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6332509</ArticleId><ArticleId IdType="pubmed">30671016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A., Valentini M.C., Chio A. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG pet study in ALS of spinal and bulbar onset. Eur. J. Nucl. Med. Mol. Imaging. 2012;39(2):251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">22089661</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A., Engler H., Blomquist G. Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 pet. J. Neurol. Sci. 2007;255(1&#x2013;2):17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17346749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A., Pagani M., Montuschi A. The metabolic signature of C9ORF72-related ALS: FDG pet comparison with nonmutated patients. Eur. J. Nucl. Med. Mol. Imaging. 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter M.K., Gendron T.F. Biomarkers for amyotrophic lateral sclerosis and frontotemporal dementia associated with hexanucleotide expansion mutations in C9orf72. Front. Neurol. 2018;9:1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289985</ArticleId><ArticleId IdType="pubmed">30568632</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioro E.P., Majors A.W., Mitsumoto H. 1H-MRS evidence of neurodegeneration and excess glutamate&#x202f;+&#x202f;glutamine in ALS medulla. Neurology. 1999;53(1):71&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">10408539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G., Bowen B.C., Pattany P.M. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J. Neurol. Sci. 1999;169(1&#x2013;2):84&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivak S., Bittsansky M., Kurca E. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology. 2010;52(12):1079&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pubmed">20369234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S. Magnetic resonance spectroscopy in ALS. Front. Neurol. 2019;10:482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524558</ArticleId><ArticleId IdType="pubmed">31133975</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans M.C., Modo M., Talbot K. Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13(3):288&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">22117132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede Deciphering neurodegeneration: A paradigm shift from focality to connectivity. Neurology. 2017;89:1758&#x2013;1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">28954879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P. The histological correlates of imaging metrics: postmortem validation of in vivo findings. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7-8):457&#x2013;460. Epub 2019 Jul 11. No abstract available. PMID: 31293187.</Citation><ArticleIdList><ArticleId IdType="pubmed">31293187</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang D.W., Yang Q., Wang H.X. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2004;20(7):1745&#x2013;1751.</Citation><ArticleIdList><ArticleId IdType="pubmed">15379995</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G., El Mendili M.M., Bede P. Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. J. Neurol. Neurosurg. Psychiatry. 2018;89:1220&#x2013;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">29353238</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G., El Mendili M.M., Lenglet T. The spinal and cerebral profile of adult spinal-muscular atrophy: a multimodal imaging study. Neuroimage Clin. 2019;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6413472</ArticleId><ArticleId IdType="pubmed">30522974</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Agosta F., Bede P. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012;6(3):319&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">22731907</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Hardiman O., Bede P. Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol. 2017;17(1):73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5393027</ArticleId><ArticleId IdType="pubmed">28412941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Iyer P.M., Schuster C. The selective anatomical vulnerability of ALS: 'disease-defining' and 'disease-defying' brain regions. Amyotroph. Lateral Scler. Frontotemporal Degener. 2016;17(7&#x2013;8):561&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">27087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V., Pradat P.F., Querin G. Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front. Neurosci. 2019;13:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Hardiman O., Bede P. Development of an automated MRI-based diagnostic protocol for amyotrophic lateral sclerosis using disease-specific pathognomonic features: a quantitative disease-state classification study. PLoS One. 2016;11(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5132189</ArticleId><ArticleId IdType="pubmed">27907080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Iyer P.M., Finegan E. Virtual brain biopsies in amyotrophic lateral sclerosis: diagnostic classification based on in vivo pathological patterns. Neuroimage Clin. 2017;15:653&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5479963</ArticleId><ArticleId IdType="pubmed">28664036</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Kiernan M., Mitsumoto H. Amyotrophic lateral sclerosis: a long preclinical period? J. Neurol. Neurosurg. Psychiatry. 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24648037</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G., Bede P., El Mendili M.M. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: a longitudinal neuroimaging study. Ann. Neurol. 2019;86(2):158&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">31177556</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke R.A.L., Proudfoot M., Talbot K. The two-year progression of structural and functional cerebral mri in amyotrophic lateral sclerosis. NeuroImage Clin. 2018;17:953&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752097</ArticleId><ArticleId IdType="pubmed">29321969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Hardiman O. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotroph. Lateral Scler. Frontotemporal Degener. 2018;19(3&#x2013;4):232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Gorges M., Kassubek R. Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: a tract of interest-based MRI study. NeuroImage Clin. 2018;18:762&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959739</ArticleId><ArticleId IdType="pubmed">29785360</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Weehaeghe D., Ceccarini J., Delva A. Prospective validation of 18F-FDG brain pet discriminant analysis methods in the diagnosis of amyotrophic lateral sclerosis. J. Nucl. Med. 2016;57(8):1238&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pubmed">26940764</ArticleId></ArticleIdList></Reference><Reference><Citation>Butman J.A., Floeter M.K. Decreased thickness of primary motor cortex in primary lateral sclerosis. Am. J. Neuroradiol. 2007;28(1):87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">17213431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Kasper E., Machts J. Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J. Neurol. 2013;260(11):2856&#x2013;2864.</Citation><ArticleIdList><ArticleId IdType="pubmed">23996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N.K., Kwan J.Y., Danielian L.E. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain. 2011;134(9):2642&#x2013;2655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170531</ArticleId><ArticleId IdType="pubmed">21798965</ArticleId></ArticleIdList></Reference><Reference><Citation>Unrath A., Muller H.-.P., Riecker A. Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum. Brain Mapp. 2010;31(11):1727&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871219</ArticleId><ArticleId IdType="pubmed">20336652</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Galantucci S., Riva N. Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS. Hum. Brain Mapp. 2014;35(4):1710&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6869498</ArticleId><ArticleId IdType="pubmed">23633431</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark M.G., Smallwood Shoukry R., Huang C.J. Loss of functional connectivity is an early imaging marker in primary lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2018;19(7&#x2013;8):562&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456429</ArticleId><ArticleId IdType="pubmed">30299161</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H., Cheng B., Katz I.B. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology. 2009;72(22):1948&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pubmed">19487653</ArticleId></ArticleIdList></Reference><Reference><Citation>Barritt A.W., Gabel M.C., Cercignani M. Emerging magnetic resonance imaging techniques and analysis methods in amyotrophic lateral sclerosis. Front. Neurol. 2018;9:1065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288229</ArticleId><ArticleId IdType="pubmed">30564192</ArticleId></ArticleIdList></Reference><Reference><Citation>Broad R.J., Gabel M.C., Dowell N.G. Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS. J. Neurol. Neurosurg. Psychiatry. 2018;90:404&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6581155</ArticleId><ArticleId IdType="pubmed">30361295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>